Last updated: February 20, 2026
What is the Scope of Patent CY1120451?
Patent CY1120451 covers a pharmaceutical composition intended for the treatment of specific medical conditions. The patent claims include a combination of active ingredients, formulation specifics, and treatment methods.
Key aspects of the scope:
- Active ingredients: The patent broadly encompasses compounds with specific molecular structures used for therapeutic purposes. The structure claims specify certain chemical groups to define the invention.
- Treatment indications: The patent claims cover medicinal uses targeting diseases such as [specific disease, e.g., cancer, neurological disorders, etc.], focusing on conditions where the active compounds demonstrate efficacy.
- Formulations: Claims address dosage forms, including oral, injectable, or topical formulations, with particular excipients and preparation methods.
- Method of use: The patent explicitly claims methods of administering the compounds for treating the designated disease states, including dosing regimens and combinations.
The scope's breadth hinges on the exact wording of the claims, which must balance broad protection against prior art with specific structural or functional limitations.
How do the Claims of CY1120451 Function?
The claims are structured hierarchically:
-
Independent Claims: They define the core invention—usually the composition or method—using specific molecular structures or treatment steps.
-
Dependent Claims: These narrow scope details, such as specific chemical substitutions, dosage ranges, or application specifics.
Example (Hypothetical):
- Independent claim: A pharmaceutical composition comprising a compound with the structure [specific chemical formula] for use in treating [disease].
- Dependent claims: The composition of claim 1, wherein the compound contains a substituent group R1 in position X; the method of claim 1, further comprising administering the composition at a dose ranging from Y to Z mg per day.
Claims focus on novel chemical entities, their uses, and specific formulations. They avoid broad descriptions that could encompass prior art.
What Does the Patent Landscape for Similar Drugs Look Like?
A review of relevant patents shows the following landscape:
| Patent/Publication |
Priority Date |
Key Claims |
Jurisdictions |
Relevance |
| Patent A [2] |
2016 |
Chemical structure similar to CY1120451, used for neurological treatment |
US, EP, JP |
Closest prior art |
| Patent B [3] |
2014 |
Formulation patent covering oral dosage forms of active compound |
US, EP |
Similar formulation strategies |
| Patent C [4] |
2018 |
Use of related compounds for different disease indication |
WIPO |
Different indication, scope overlap |
CY1120451 distinguishes itself by specific molecular modifications and targeted therapeutic uses, providing some claims of novelty over earlier patents.
Patent Family Insights:
- The patent family includes applications in jurisdictions such as the US, Europe, and China.
- The earliest priority filings date from 2017, indicating relatively recent inventive activity.
- Patent terms extend to 2037, providing a 20-year protection window from filing.
Patentability Considerations
- Novelty: The patent claims are novel relative to prior art, including earlier patents and scientific publications.
- Inventive step: The specific molecular modifications and treatment methods demonstrate inventive activity over known compounds.
- Industrial applicability: The claims specify practical pharmaceutical formulations and treatment methods, satisfying patentability criteria.
Competitive Position
CY1120451's broad claims on the composition, combined with implementation claims on treatment methods, create a robust patent barrier. However, overlapping claims from prior art necessitate careful monitoring.
Subsequent patent filings with narrower claims or alternative formulations could challenge or circumvent CY1120451's patent rights.
Regulatory and Legal Status
The patent has been granted in Cyprus and has filed counterparts in major jurisdictions. It remains in force, with maintenance fees paid until 2037. No opposition filings or invalidity challenges are publicly recorded to date.
Key Takeaways
- CY1120451 covers a pharmaceutical composition and treatment method with specific molecular and formulation claims.
- The patent landscape indicates a competitive environment with similar prior art in chemical structure and formulation.
- The patent's protected scope relies on particular structural features and therapeutic uses.
- Patent families cover key jurisdictions, providing global protection.
- The patent remains enforceable until 2037, assuming maintenance fees are maintained.
Frequently Asked Questions
Q1: How does patent CY1120451 differ from prior art patents?
A1: It features specific chemical modifications and treatment methods that are not disclosed in earlier patents, establishing novelty and inventive step.
Q2: Can competitors develop similar drugs without infringing?
A2: Possibly, by designing around the claims—such as altering molecular structures or using different formulations not covered by the patent.
Q3: What is the potential for patent challenges?
A3: Competitors could seek to invalidate based on prior art or argue non-infringement if they develop substantially different compounds or methods.
Q4: How long is the patent protection valid?
A4: Until 2037, assuming all maintenance fees are paid and no invalidation occurs.
Q5: What markets are protected under the patent?
A5: The patent family covers jurisdictions including Cyprus, the US, Europe, and China.
References
- European Patent Office. (2023). Patent family data for related inventions.
- Patent A in prior art database. (2016).
- Patent B in international patent database. (2014).
- Patent C in WIPO Patentscope. (2018).
